Pyrogen-free borosilicate glass test tubes with screw-caps. Recommended for gel-clot testing.
For determination which of the two Nucleofector® Kits is best suited for efficient transfection of a specific mouse embryonic fibroblast clone in Nucleofector® I/II/2b Device
Culture system containing MSCBM® Basal Media (PT-3238) and MSCGM® SingleQuots® Supplement Kit (PT-4105) required for proliferation of human bone marrow derived mesenchymal stem cells.
ProCHO® 4 Protein-free CHO Medium with 0.1% Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine, 1 L
Cryopreserved ampule of Prostate Epithelial Cells (PrEC) containing ≥500,000 cells
Cryopreserved ampule of Small Airway Epithelial Cells (SAEC) containing ≥500,000 cells.
D-HCAEC, Human Coronary Artery Endothelial Cells, Diabetes T2
D-SAEC-COPD, Small Airway Epithelial Cells from donors with COPD
D-HPAEC, Pulmonary Artery Endothelial Cells, Diabetes T1
-
References - X-Vivo™Overview of relevant references
-
Primary Normal Human Cells and MediaIn Vivo Relevance. In Vitro Results. Updated and revised cell content.
-
X-VIVO Reference Guide 2025A curated list of peer-reviewed articles related to X-VIVO RUO media as used for culturing different primary cells and is a resource for potential consumers to find scientific data.
-
Building Better In Vitro Models Using the Quasi Vivo® SystemOverview webinar providing details and application data using the Quasi Vivo® Systems delivered by Dr. Kelly Davidge, Scientist at Kirkstall Inc. -
Terms and Conditions TheraPEAK® T-VIVO® Sample Request ProgramTerms and Conditions TheraPEAK® T-VIVO® Sample Requests
-
Instructions for Use – TheraPEAK® X-VIVO® Cell Culture MediumInstructions for how to use the X-VIVO® Media Series
-
TheraPEAK® T-VIVO® Cell Culture Medium – OverviewView or download this document for a comprehensive overview and learn how the chemically defined TheraPEAK® T-VIVO® Medium enhances T-cell culture and accelerates therapy development.
-
TheraPEAK® X-VIVO® Hematopoietic Cell Culture MediumSerum-free, GMP produced medium for cell therapy applications
-
Non-viral Gene Modification for Ex-vivo Cell TherapyIn this interview our Director Transfection R&D discusses the advantages of non-viral transfection technologies for CRISPR- or transposon-based genetic modification cell and gene therapy.
-
A Novel In Vitro Liver Cell Culture Flow System Allowing Long-Term Metabolism and Hepatotoxicity Studies]Manuscript published in Applied In Vitro Toxicology journal describes improvement of CYP450 phenotype of primary cryopreserved hepatocytes using Quasi Vivo® System